NM_004380.3:c.6609A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004380.3(CREBBP):​c.6609A>G​(p.Gln2203Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00173 in 1,612,628 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q2203dup) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0094 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00093 ( 19 hom. )

Consequence

CREBBP
NM_004380.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.238

Publications

3 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-3728438-T-C is Benign according to our data. Variant chr16-3728438-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.238 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00936 (1424/152136) while in subpopulation AFR AF = 0.0317 (1315/41488). AF 95% confidence interval is 0.0303. There are 14 homozygotes in GnomAd4. There are 674 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1424 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.6609A>Gp.Gln2203Gln
synonymous
Exon 31 of 31NP_004371.2Q92793-1
CREBBP
NM_001079846.1
c.6495A>Gp.Gln2165Gln
synonymous
Exon 30 of 30NP_001073315.1Q92793-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.6609A>Gp.Gln2203Gln
synonymous
Exon 31 of 31ENSP00000262367.5Q92793-1
CREBBP
ENST00000382070.7
TSL:1
c.6495A>Gp.Gln2165Gln
synonymous
Exon 30 of 30ENSP00000371502.3Q92793-2

Frequencies

GnomAD3 genomes
AF:
0.00938
AC:
1426
AN:
152018
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0318
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00582
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00259
AC:
631
AN:
243812
AF XY:
0.00203
show subpopulations
Gnomad AFR exome
AF:
0.0344
Gnomad AMR exome
AF:
0.00230
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000464
Gnomad OTH exome
AF:
0.00168
GnomAD4 exome
AF:
0.000931
AC:
1360
AN:
1460492
Hom.:
19
Cov.:
33
AF XY:
0.000787
AC XY:
572
AN XY:
726584
show subpopulations
African (AFR)
AF:
0.0313
AC:
1048
AN:
33442
American (AMR)
AF:
0.00306
AC:
137
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86198
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52912
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000369
AC:
41
AN:
1111450
Other (OTH)
AF:
0.00208
AC:
125
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
86
172
259
345
431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00936
AC:
1424
AN:
152136
Hom.:
14
Cov.:
32
AF XY:
0.00906
AC XY:
674
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0317
AC:
1315
AN:
41488
American (AMR)
AF:
0.00582
AC:
89
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67970
Other (OTH)
AF:
0.00805
AC:
17
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
75
150
225
300
375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00495
Hom.:
7
Bravo
AF:
0.0124

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Rubinstein-Taybi syndrome (1)
-
-
1
Rubinstein-Taybi syndrome due to CREBBP mutations;C5193034:Menke-Hennekam syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.026
DANN
Benign
0.29
PhyloP100
-0.24
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62636220; hg19: chr16-3778439; COSMIC: COSV99269036; COSMIC: COSV99269036; API